S&P 500 Industrials Sector SEC Filings — February 23, 2026

24-02-2026

Ferguson Enterprises Inc. /DE/ filed a Form 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure in the US equity markets. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details.

• ·Sector: not specified
• ·Filing size: 483 KB
• ·AccNo: 0002011641-26-000002

24-02-2026

ALBANY INTERNATIONAL CORP /DE/ filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-010871), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing focused on earnings-related disclosures.

24-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary.

24-02-2026

Home Depot, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided filing information.

24-02-2026

BANK OF HAWAII CORP filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer involved, position, reason for change, or any quantitative metrics are disclosed.

24-02-2026

Invesco Mortgage Capital Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement under Item 1.01 and termination of a material definitive agreement under Item 1.02. Item 9.01 includes financial statements and exhibits. No specific transaction values, terms, parties, financial impacts, or strategic details are disclosed.

24-02-2026

Tidewater Inc filed a Form 8-K on February 24, 2026 (AccNo: 0001104659-26-018759), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, transaction value, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

24-02-2026

MacroGenics Inc. filed a Form 8-K on February 24, 2026, under Item 8.01 reporting Other Events. No specific details regarding the nature of the events, financial metrics, transaction values, or impacts are disclosed. No positive or negative metrics are mentioned.

24-02-2026

Protagenic Therapeutics, Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01) and unregistered sales of equity securities (Item 3.02). Other events are noted under Item 8.01, with financial statements and exhibits provided under Item 9.01. No quantitative financial metrics, deal values, or specific parties are disclosed.

24-02-2026

Atlantic Union Bankshares Corp filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions affected, reasons for changes, timing details, or quantitative data are provided.

24-02-2026

Axogen, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the available information. No positive or negative performance indicators, period-over-period changes, or strategic details are explicitly stated.

24-02-2026

Advanced Micro Devices Inc filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction sizes, financial impacts, or other metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks quantitative or qualitative context for assessment.

24-02-2026

24-02-2026

Repligen Corp filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-065246), reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing information. This represents a standard voluntary earnings disclosure with attached materials.

24-02-2026

Cipher Mining Inc. filed a multi-item Form 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This filing discloses financial results alongside governance changes, but specific details on operations, amendments, financial metrics, or performance are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional impacts are provided in the available information.

24-02-2026

Kiniksa Pharmaceuticals International, plc filed an 8-K on February 24, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

24-02-2026

Twin Vee PowerCats, Co. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)
• ·Accession Number: 0001731122-26-000289
• ·File size: 669 KB

24-02-2026

NexPoint Residential Trust, Inc. filed an 8-K on February 24, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific financial metrics, period-over-period comparisons, or performance details such as revenue, earnings, margins, or changes are mentioned. This is a standard voluntary filing for financial results with no quantified positive or negative impacts disclosed.

24-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-24 under Item 3.01 providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, in the context of a merger/acquisition event. No quantitative data, deal terms, financial metrics, parties involved, or other specific details are disclosed. Sector is not specified.

24-02-2026

Advantage Solutions Inc. filed a Form 8-K on 2026-02-24 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing, but specific details of the agreement, transaction value, financial impacts, or any positive/negative metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional indicators are provided.

24-02-2026

Golden Matrix Group, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing information. No positive or negative metrics are mentioned.

24-02-2026

Adial Pharmaceuticals, Inc. filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements/exhibits are disclosed in the filing summary provided. This is a multi-item, likely voluntary disclosure without quantified financial metrics or directional impacts.

24-02-2026

Edesa Biotech, Inc. filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, quantitative metrics, or strategic implications are disclosed in the filing metadata. The filing size is 204 KB with Accession Number 0001171843-26-001046.

24-02-2026

NEW PEOPLES BANKSHARES INC filed a Form 8-K on February 24, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other event, transaction, financial impacts, or contents of the exhibits are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or strategic implications are provided.

24-02-2026

Jazz Pharmaceuticals plc filed an 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing summary. Sector information is not specified.

24-02-2026

Inogen Inc filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or other metrics are provided in the available information. No period-over-period comparisons, guidance, or balance sheet details are mentioned.

24-02-2026

Supernus Pharmaceuticals, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001356576-26-000004), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are mentioned in the filing. Sector information is not specified.

24-02-2026

BCB Bancorp Inc filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. Filing accession number 0001193125-26-066971, size 136 KB.

24-02-2026

Tanger Inc. filed an 8-K on 2026-02-24 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. This is a multi-item voluntary filing typical for earnings releases. No specific revenue, earnings, guidance, comparisons, or other quantitative financial metrics are disclosed.

• ·AccNo: 0001628280-26-011057
• ·File Size: 27 MB
• ·Event Type: Financial Results

24-02-2026

CCC Intelligent Solutions Holdings Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-066949), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

24-02-2026

Climb Global Solutions, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001437749-26-005335), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

24-02-2026

Zeta Global Holdings Corp. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-066951), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard voluntary earnings release filing with no quantitative data available.

24-02-2026

Finward Bancorp filed an 8-K on 2026-02-24 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 8.01 covers other events, but no specific details on individuals, reasons, timing, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

24-02-2026

BridgeBio Pharma, Inc. filed an 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified metrics available.

24-02-2026

ServisFirst Bancshares, Inc. filed a Form 8-K on February 24, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing provides voluntary public disclosure of material information to comply with Regulation FD, with exhibits attached for support. No specific financial metrics, transactions, positive or negative changes, or quantitative data are disclosed in the filing metadata.

24-02-2026

BTC Development Corp. filed a Form 8-K on February 24, 2026 (AccNo: 0001213900-26-019870, Size: 265 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are provided.

24-02-2026

Day One Biopharmaceuticals, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-066926), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or quantitative data are disclosed in the provided filing details. This is a multi-item filing focused on financial results disclosure.

• ·Filing size: 29 MB
• ·Sector: NOT_DISCLOSED

24-02-2026

MGE Energy Inc filed a Form 8-K on February 24, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific financial metrics, revenue, earnings, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

24-02-2026

Adtalem Global Education Inc. filed an 8-K on 2026-02-24 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), with file size 18 MB. No specific events, transactions, financial metrics, positive or negative changes, or other details are disclosed in the provided filing summary.

24-02-2026

Resideo Technologies, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001740332-26-000003, Size: 729 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are explicitly stated in the provided filing information. No positive or negative metrics, guidance, or balance sheet effects are detailed.

24-02-2026

Valley National Bancorp filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transactions, or directional performance indicators mentioned.

24-02-2026

Leggett & Platt Inc filed an 8-K on February 24, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or financial impacts were provided.

24-02-2026

Light & Wonder, Inc. filed an 8-K on February 24, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive, negative, or flat metrics are mentioned.

24-02-2026

Liberty Global Ltd. filed an 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No quantitative details such as transaction value, financial impacts, or performance metrics are disclosed.

24-02-2026

Amplitude, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.

24-02-2026

Alphatec Holdings, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure with attached exhibits.

24-02-2026

Slide Insurance Holdings, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-067069, Size: 688 KB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no directional performance data available.

24-02-2026

DENTSPLY SIRONA Inc. filed an 8-K on 2026-02-24 disclosing changes related to departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. Specific details on affected positions, individuals, reasons for change, or any quantitative impacts are NOT_DISCLOSED.

24-02-2026

Republic Bancorp Inc /KY/ filed an 8-K on February 24, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. This is a voluntary disclosure with no quantitative data or directional impacts mentioned.

24-02-2026

Business First Bancshares, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons provided.

24-02-2026

GLOBAL INDUSTRIAL Co filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011155, Size: 430 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results and related exhibits, but no specific revenue, earnings, guidance, or performance metrics are mentioned. No positive or negative financial changes are detailed.

24-02-2026

Trailblazer Merger Corp I filed an 8-K on 2026-02-24 (AccNo: 0001213900-26-019945, Size: 334 KB) disclosing Item 5.07 regarding Submission of Matters to a Vote of Security Holders in connection with a Merger/Acquisition event. No specific details on vote results, parties involved, deal structure, financial terms, or metrics are provided. Sector is not specified.

24-02-2026

Bark, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011180), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed. Sector is not specified.

24-02-2026

Genesis Energy LP filed a multi-item Form 8-K on 2026-02-24 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the core transaction, dollar values, financial impacts, or quantitative metrics are provided in the available information. All numerical data, period-over-period comparisons, and strategic implications remain NOT_DISCLOSED.

24-02-2026

Ameris Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000351569-26-000026, Size: 142 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Specific details including key positions affected, individuals involved, reasons for the change, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or governance implications are mentioned.

• ·Filing size: 142 KB

24-02-2026

Fifth Third Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000035527-26-000126), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance metrics, or scheduled events are mentioned.

24-02-2026

Bank of Marin Bancorp filed an 8-K on February 24, 2026, under Item 4.02 announcing non-reliance on previously issued financial statements or a related audit report or completed interim review. This disclosure signals potential accounting irregularities or material weaknesses requiring restatement. No specific affected periods, financial impacts, or quantitative details are disclosed.

24-02-2026

VenHub Global, Inc. filed a Form 8-K on February 24, 2026, reporting solely under Item 8.01 Other Events. No details on the core event, financial impacts, transactions, or metrics are disclosed. This is a voluntary, single-item informational filing with no quantitative data provided.

24-02-2026

Rank One Computing Corp dba ROC filed an 8-K on February 24, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific details, dollar values, financial metrics, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary. This is a multi-item mandatory filing with no quantitative impacts or strategic context provided.

24-02-2026

SPACSphere Acquisition Corp. filed an 8-K on 2026-02-24 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), announcing events related to a merger/acquisition. No specific deal terms, parties, valuations, financial metrics, synergies, regulatory pathways, or shareholder impacts were disclosed. No quantitative data, period-over-period comparisons, or scheduled events were mentioned.